Details
Title
Author Correction: Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites
Author
Crooks, M. G. 1 ; Cummings, H. 2 ; Morice, A. H. 1
; Sykes, D. 1 ; Brooks, S. 3 ; Jackson, A. 3 ; Xu, Y. 3
1 University of Hull, Hull York Medical School, Hull, UK (GRID:grid.9481.4) (ISNI:0000 0004 0412 8669); Hull University Teaching Hospitals NHS Trust, Hull, UK (GRID:grid.9481.4) (ISNI:0000 0004 0412 8669)
2 Hull University Teaching Hospitals NHS Trust, Hull, UK (GRID:grid.9481.4) (ISNI:0000 0004 0412 8669)
3 AstraZeneca, Medical Affairs, London, UK (GRID:grid.417815.e) (ISNI:0000 0004 5929 4381)
; Sykes, D. 1 ; Brooks, S. 3 ; Jackson, A. 3 ; Xu, Y. 3 1 University of Hull, Hull York Medical School, Hull, UK (GRID:grid.9481.4) (ISNI:0000 0004 0412 8669); Hull University Teaching Hospitals NHS Trust, Hull, UK (GRID:grid.9481.4) (ISNI:0000 0004 0412 8669)
2 Hull University Teaching Hospitals NHS Trust, Hull, UK (GRID:grid.9481.4) (ISNI:0000 0004 0412 8669)
3 AstraZeneca, Medical Affairs, London, UK (GRID:grid.417815.e) (ISNI:0000 0004 5929 4381)
Pages
19
Publication year
2024
Publication date
2024
e-ISSN
20551010
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3077577931
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.